BP000156-CYT-150: Recombinant Rat Interleukin 33 (IL-33) Protein
Source: E. coli-derived.
The ED50 was determined by the dose-dependent stimulation of the proliferation of murine D10S cells is <0.5 ug/ml, corresponding to a specific activity of >2,000,000 units/mg.
Purity: > 95.0% by SDS-PAGE.BP000155-CYT-584: Recombinant Human IL-32alpha
Source: E. coli-derived.
Human IL-32 alpha activity is measured via the dose-dependent induction of TNF-alpha in the human THP-1 monocytic cell line.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000155-CYT-648: Recombinant Human IL-32alpha, His Tag
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000154-CYT-625: Recombinant Human Interleukin 31 (IL-31) Protein
Source: E. coli-derived.
The ED50 was determined by its ability to activate STAT following receptor ligand interaction and found to be <5 ug/ml, corresponding to a specific activity of 200,000 units.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000169-CYT-604: Recombinant Mouse Interleukin-31 (IL-31) Protein
Source: E. coli-derived.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000153-CYT-383: Recombinant Rat Interleukin-3 (IL3) Protein
Source: E. coli-derived.
The ED50 = 3-10 ug/ml corresponding to a specific activity of 100,000-333,334 IU/mg determined by the dose dependent proliferation of murine NFS-60 cells.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000153-CYT-482: Recombinant Human Interleukin-3 (IL3) Protein, His Tag
Source: E. coli-derived.
The ED50 for this effect is < 0.53 ug/ml. Measured in a cell proliferation assay using TF1 human erythroleukemic cells.
Purity: > 90% by SDS-PAGE.BP000153-CYT-417: Recombinant Human Interleukin-3 (IL3) Protein, Sf9
Source: Insect Cells-derived.
The ED50 as determined by the dose-dependant stimulation of TF-1 cells is < 0.1 ug/ml, corresponding to a Specific Activity of 10 MIU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000153-CYT-722: Recombinant Canine Interleukin-3 (IL3) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of TF-1 cells is < 0.2 ug/ml, corresponding to a Specific Activity of 5,000,000 IU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP002004-PRO-267: Recombinant Human Small Ubiquitin-related modifier 3 (SUMO3) Protein
Source: E. coli-derived.
Purity: > 95% by reducing SDS-PAGE and SEC-HPLC.